welcome
Guardian

Guardian

Health

Health

The toxic debate about obesity rages on. But at least we know if Mounjaro or Wegovy is better for weight loss | Zoe Williams

Guardian
Summary
Nutrition label

60% Informative

Mounjaro, reducing weight by 20% , might end up on top in the long run.

Ozempic is the same drug as Wegovy , just with a lower concentration of the active ingredient, semaglutide, and is used to treat type 2 diabetes.

Obesity is deployed in general analysis to explain a huge range of intractable problems.

There have always been people arguing forcefully that weight gain is created by the economy, by agriculture, by industry, by systems but none of that has impeded the discursive juggernaut heading towards a post-NHS , post-welfare-state reality. Effective weight-loss drugs, however those really would get sand in the gears. Remove obesity and we have no way of blaming, policing or judging one another, and we’d be back to square one, Beveridge or bust. Which I, personally, would be fine with. Zoe Williams is a Guardian columnist.

VR Score

43

Informative language

30

Neutral language

28

Article tone

informal

Language

English

Language complexity

52

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

detected

Time-value

medium-lived

Affiliate links

no affiliate links